The involvement of the vasa vasorum in the development of vasculitis in animal model of Kawasaki disease by Akiko Hamaoka-Okamoto et al.
Hamaoka-Okamoto et al. Pediatric Rheumatology 2014, 12:12
http://www.ped-rheum.com/content/12/1/12RESEARCH Open AccessThe involvement of the vasa vasorum in the
development of vasculitis in animal model of
Kawasaki disease
Akiko Hamaoka-Okamoto1*, Chinatsu Suzuki1, Tomoyo Yahata1, Kazuyuki Ikeda1, Noriko Nagi-Miura2,
Naohito Ohno2, Yoshinori Arai3, Hideo Tanaka4, Tetsuro Takamatsu4 and Kenji Hamaoka1Abstract
Background: Kawasaki Disease (KD) involves a diffuse and systemic vasculitis of unknown etiology that mainly
affects infants and children. Although a considerable number of analyses of the clinical, histopathological and
molecular biological details underlying the mechanism responsible for the development of coronary arterial lesions,
it is still poorly understood.
The purpose of this study was to analyze the state of angiogenesis, vasculogenesis and the distribution of blood
vessels using an animal model of KD like vasculitis. We investigated the involvement of the vasa vasorum from the
adventitia in the vascular involvement and the development of the disease state by performing sequential
histopathology, scanning electron microscopy (SEM) and micro computed tomography (CT) studies using a murine
model of vasculitis induced by the Candida albicans water-soluble fraction (CAWS).
Methods: To prepare the animal model of KD like vasculitis, CAWS was intraperitoneally injected into C57BL/6N
mice for five consecutive days as reported by Ohno et al. We observed the changes of the vasa vasorum at the
aorta and the orifices of the coronary arteries by SEM and micro CT, and also compared the neovascularization at
the media and adventitia of the aorta by an immunohistochemical analysis.
Results: As previously reported, obvious inflammation was detected two weeks after the injection of CAWS, and
also intimal thickening was observed three weeks after the injection. We found that the vasa vasorum in the
adventitia of the aorta was increased in the model mice. The vasa vasorum started increasing one week after the
injection of CAWS, before any obvious vasculitis was microscopically detected.
Conclusion: The present results indicate that the vasculitis in Kawasaki disease starts as a disorder of the vasa
vasorum.
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Kawasaki disease (KD) involves diffuse, systemic vascu-
litis of unknown etiology and pathogenesis, and predom-
inantly affects infants and children [1-3]. The incidence
of KD has steadily increased since it was first reported,
and more than 12,000 people are diagnosed with KD
each year in Japan. The well-known sequelae of KD* Correspondence: ahamaoka@koto.kpu-m.ac.jp
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article, unless otherwise stated.include coronary aneurysms, which occur in approxi-
mately 5% of the KD patients [4]. With time, an
aneurysm may cause stenotic lesions or ischemic heart
disease, even in children [5-7].
Intravascular immunoglobulin (IVIG) therapy can
greatly decrease the chances of complications of coron-
ary arterial lesions (CALs), though 10–15% of the pa-
tients are refractory to IVIG. In these cases, the
incidence of CALs tends to be much higher.
Since KD was first described by Kawasaki in 1967,
many clinical, histopathological and or molecular bio-
logical studies have been performed to investigate theMed Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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however, the underlying mechanism remains unclear
[2,3,8,9]. Coronary arteritis in KD is considered to begin
with edematous changes in the media, developing into
inflammatory changes in the intima and adventitia,
which finally evolve into the panvasculitis observed dur-
ing autopsies [8].
In contrast, recent studies using various animal
models of KD like vasculitis have indicated that the in-
flammatory changes in the adventitia occur prior to the
changes in the intima [10-12]. In 1975, Onouchi et al.
suggested that the vasa vasorum, which supplies nutri-
tion to the walls of blood vessels, might contribute to
the progression of vasculitis in KD, beginning with se-
vere tissue destruction at the vasa vasorum in the adven-
titia [9]. Although there have not been detailed
pathological studies on the significance of the vasa
vasorum in KD, recent studies using the advanced im-
aging analyses have shown that the abnormal prolifera-
tion of the vasa vasorum was associated with plaque
formation and the destabilization of lesions during the
development of arterial sclerosis. In chronic inflamma-
tory diseases such as arterial sclerosis, the abnormal pro-
liferation of the vasa vasorum may provide an infiltrative
route for inflammatory cells from the adventitia, and this
accumulation of inflammatory cells promotes the in-
flammation [13-15]. Thus, we hypothesized that the vasa
vasorum might serve as the initiator of vasculitis in KD.
Various animal models have been developed to investi-
gate KD vasculitis. In 1979, Murata and Naoe et al. first
reported that the Candida albicans derived substance
(CADS) isolated from the feces of patients with KD
causes coronary arteritis as seen in KD [16]. Subsequent
studies revealed that the water-soluble extracellular poly-
saccharide fraction (CAWS) obtained from the culture
supernatant of Candida albicans resulted in a stronger
but similar vasculitis that occurred more frequently than
that following exposure to CADS. Therefore, CAWS-
induced vasculitis has become widely adopted as a uni-
versal animal model for KD like vasculitis [17-25].
The purpose of this study was to delineate the involve-
ment of the vasa vasorum in the development of KD
vasculitis by examining its proliferation and distribution
using histopathological or micro-computed tomography
(CT) and scanning electron microscope (SEM) studies.
KD is associated with a low mortality rate, and due to
the low availability of autopsied hearts, we used the
CAWS animal model for this purpose.
Methods
Animals
All experimental procedures were approved by the
Committee for Animal Research, Kyoto Prefectural Uni-
versity of Medicine. A total of 24 four-week-old maleC57BL/6N mice were obtained from SHIMIZU Labora-
tory Supplies Co., Ltd. (Kyoto, Japan) and were randomly
divided into six experimental groups: control and model
mice evaluated at one week, two weeks and three weeks
after the administration of CAWS.
CAWS was kind gift from Tokyo University of Pharmacy
and Life Science and 0.2 mL (20 mg/mL) was administered
intraperitoneally to the model mice daily for five consecu-
tive days starting at the age of five weeks.
Histopathology
After heparin was administered, anesthesia was induced
with a fatal dose of pentobarbital sodium. The chest was
then opened, and the abdominal aorta was cannulated
and infused with saline until the venous effluent was free
of blood. Sections of the heart at the level of the aortic
valves were obtained.
Tissue specimens were fixed in 20% formalin, embedded
in paraffin and sectioned at 4 μm-thick slices. First,
hematoxylin and eosin (HE)- and elastic van Gieson
(EVG)-stained sections were examined by light microscopy.
Next, immunohistochemical studies for CD3 and
MPO were performed to detect the type of inflammatory
cells. Some sections were deparaffinized in xylene and
ethanol rinses. Only sections for CD3 were activated by
boiling for 5 min in a citrate buffer (0.01 M) at pH 9.0
in a microwave. No pretreatment was needed for MPO.
After blocking of non- specific binding, the sections
were incubated at 4 °C overnight in a humidified slide
chamber with polyclonal antibodies (Dako Cytomation)
for CD3 (dilution 1:400) and MPO (dilution 1:600). After
incubation with the corresponding secondary antibody
for 30 minutes, the antibody binding was revealed using
H2O2 and diaminobenzidine. Counterstaining was per-
formed with hematoxylin, and sections were examined
by light microscopy.
Immunofluorescent studies were also performed using
Biotin-conjugated Isolectin IB4 (Molecular Probes, Inc.).
Some sections were deparaffinized in xylene and ethanol
rinses, and activated by boiling for 5 min in a citrate buffer
(0.01 M) at pH 6.0 in a microwave. The sections were in-
cubated at 4°C overnight in a humidified slide chamber
with lectin diluted at 1:200. The stained specimens were
observed using a confocal laser scanning microscope
(LSM510 ver. 4.0; Carl Zeiss CO., Ltd., Oberkochen,
Germany).
SEM
To examine the types of vessels, we investigated the ad-
ventitia of the micro- vessels using SEM [26]. After ad-
ministering lethal anesthesia with pentobarbital sodium,
a blue synthetic resin (Mercox®, DIC, Tokyo) was
injected through a 22 Ga plastic needle inserted into the
left ventricle. The sample was maintained at room
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merized. The heart, aorta and perivascular soft tissues
were then harvested en bloc. The soft tissues were dis-
solved by incubation in 20% potassium hydroxide solu-
tion at 50°C for three days. To completely dissolve theFigure 1 The four developmental stages in the murine model of Kaw
analysis. In hematoxylin and eosin (HE)-stained sections, there were some
injection (red arrows). Obvious infiltration of inflammatory cells was detecte
water-soluble fraction (CAWS) (red arrows). Three weeks after the injection,
(EVG)-stained sections, the elastic fibers started to be destroyed more than
Coronary Cusp, LCC: Left Coronary Cusp, NCC: Non Coronary Cusp, CA: Corfat tissues, the samples were incubated with proteinase
K in buffer ATL for one day. Then, the samples were
washed in 0.5% Nonidet P-40. The microvascular casts
were mounted on stubs, coated with osmium and exam-
ined using SEM (JSM-6320 F; JEOL, Tokyo).asaki disease like vasculitis based on the histopathological
inflammatory cells visible in the adventitia one week after the CAWS
d more than two weeks after the injections of the Candida albicans
marked adventitial thickening was detected.In elastica van Gieson
two weeks after the injections of CAWS (yellow arrows). RCC: Right
onary Artery.
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After lethal anesthesia with pentobarbital sodium was induced,
the thorax was opened. The abdominal aorta was cannulated
and infused with heparinized saline until the venous effluent
was free of blood. Next, the OMNIPAQUE 240 contrast agent
was infiltrated from the abdominal aorta at a steady rate.Figure 2 The results of the sections stained with antibodies for CD3 a
CD3 positive cells visible at the same position inflammatory cells were dete
(CAWS) injection (red triangles). More CD3 positive cells and some MPO po
weeks after the injections of the injection. Three weeks after the injection,The aorta and coronary arteries were scanned en bloc by a
micro CT system (Rigaku, Tokyo, Japan) [27-29]. The result-
ing three-dimensional images were displayed using the
i-view software program (Morita, Kyoto, Japan). The number
of pixels used to reconstruct the images was 500 × 500 × 500,
and the time required for filming and reconstruction wasnd MPO. In only sections with antibody for CD3, there were some
cted one week after the Candida albicans water-soluble fraction
sitive cells were detected around coronary arteries more than two
more MPO positive cells were detected.
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dimensional tomographic image simultaneously. The




One week after the CAWS injection, there were some
inflammatory cells visible in the adventitia. Two weeks
after the injection, there was clear infiltration of inflam-
matory cells and destruction of the elastic fibers. Marked
adventitial thickening was detected at time points three
or more weeks after the injection (Figure 1) [25].
Next, immunohistochemical studies were performed
to observe the type of inflammatory cells using anti-
bodies for CD3 and MPO. One week after the CAS in-
jection, there were some CD3 positive cells only around
aorta, at the same position inflammatory cells were de-
tected by HE stain. Two weeks after the injection, more
CD3 positive cells and some MPO positive cells were de-
tected even around coronary arteries. More MPO posi-
tive cells were observed at time points three or moreFigure 3 The results of the sections stained with Isolectin. A: A represe
were detected at the adventitia. B: A model mouse one week after the inje
the control, there were more Isolectin-positive endothelial cells detected a
CAWS. The Isolectin-positive cells had infiltrated inward. D: A model mouse
infiltrated all layers.weeks after the injection (Figure 2). These results by HE
stain and immunostain revealed the inflammatory cells
consisted on monocytes, lymphocytes and neutrophils.
Immunofluorescent studies were also performed to ob-
serve the appearance of the inflammatory cells at the ad-
ventitia and their infiltration inward, and we found small
vessels that were not detected in control mice. Figure 3
shows the sections stained with Isolectin. Compared with
the controls, some lectin- positive endothelial cells were
visible only at the adventitia of the aorta one week after
the injection of CAWS. Similar to the inflammatory cells,
the lectin-positive cells had infiltrated inward two weeks
after the injection, and by the following week, these cells
filled all layers.
It has been demonstrated that the vasa vasorum pro-
vides a considerable amount of blood flow to the adven-
titia and one- third of the outer layer of the media
[30-32]. Therefore, the blood vessels in the adventitia
are part of the vasa vasorum or its branches.
We also examined the size and distribution of the vasa
vasorum. As shown in Figure 4, the vasa vasorum prolif-
erated as the inflammation developed.ntative control mouse. Only a few Isolectin-positive endothelial cells
ction of Candida albicans water-soluble fraction (CAWS). Compared to
t the adventitia. C: A model mouse two weeks after the injection of
three weeks after the injection of CAWS. The Isolectin-positive cells
Figure 4 The size and distribution of small vessels, including the vasa vasorum. The X-axis shows the location of each vessel. “1” indicates
external to the vessel, and “0” indicates the center of the lumen of that vessel.The Y-axis shows the size of vessels.The vessels proliferated at the
adventitia along with the development of the inflammation.
Hamaoka-Okamoto et al. Pediatric Rheumatology 2014, 12:12 Page 6 of 9
http://www.ped-rheum.com/content/12/1/12SEM
There were many vessels surrounding the aorta and cor-
onary arteries in a net-like appearance. (Figure 5). These
were considered to be part of the vasa vasorum, because
they were arising from or invading the host vessels, as
reported previously [28,33-35].
In the group with inflammation, the number of vasa
vasorum increased. Furthermore, these networks of vasa
vasorum proliferated as the infiltration of the inflamma-
tion increased (Figure 6).
Micro CT
On scanning the aorta and coronary arteries, the left
coronary artery was found to clearly bifurcate from the
aorta in the control group and in the animal model one
week after the injection of CAWS. However, at more
than two weeks after the injection, the bifurcation of the
left coronary artery was no longer detectable due to the
leakage of contrast agent (Figure 7). This suggested that
the blood vessel wall was fragile due to the development
of inflammation.Discussion
Kawasaki disease (KD) is characterized by systemic vas-
culitis with tissue edema at the initial phase of the dis-
ease. Although the inflammation is initially localized to
the capillaries and microvessels, it eventually expands to
medium-sized muscular arteries and veins. Our study
found that the inflammation originated in the adventitia.
The inflammation enhances the expression of growth
factors and the resulting edema, leading to hypoxia due
to the proliferation of the vasa vasorum (Figures 1, 2, 3).
The proliferation of the vasa vasorum may act as a con-
duit for the entry of various growth factors [35], cyto-
kines and blood cells. The spread of the proliferated vasa
vasorum to the media thus broadens the inflammation.
In general, the inflammatory cells infiltrate from the
adventitia toward the external elastic lamina around the
Valsalva sinus and aortic valves by approximately one
week after the administration of CAWS. During the sec-
ond week, significant inflammatory changes develop
from the adventitia and media toward the intima, as
shown in Figures 1, 2 and 3, especially around the right
Figure 6 The four developmental stages of vasculitis in the murine model of Kawasaki disease as examined using a scanning electron
microscope (SEM).The proliferation of the vasa vasorum was accompanied by an increase in the inflammation.
Figure 5 An example of the small vessels around the aorta as examined by a scanning electron microscope (SEM). These vessels
surrounded the aorta and coronary arteries with a net-like appearance, and flowed into the host vessels (yellow arrows).
Figure 7 The four developmental stages of vasculitis in the murine model of Kawasaki disease as examined by micro computed
tomography (CT).The aorta and the coronary arteries were detected. Beginning approximately two weeks after the injection of Candida albicans
water-soluble fraction (CAWS), the bifurcation of the coronary arteries became unclear because of the leakage of the contrast agent.
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dominantly consisting of polymorphonuclear neutrophil
leukocytes, are observed along the elastic lamina. More
than three weeks later, the inflammation expands cir-
cumferentially to include the non-coronary sinus, and
the beginning of an abscess can be observed. Fibrinoid
necrosis is detected in the internal elastic lamina, and
the intima and the adventitia markedly thicken. There-
fore, the basic structure of blood vessels is destroyed,
and they become fragile.
In the very early phase of inflammation, although the in-
flammatory cells accumulate at the adventitia, the detach-
ment of endothelial cells or a thrombus indicative of the
damaged intima are not detected. This suggests that the
vasculitis is initiated from the side of the adventitia [36].
As the inflammatory cells infiltrate through the vasa
vasorum, the neogenesis of more vasa vasorum occurs
inward, and the inflammatory lesion expands along the
elastic lamina.
While the arteries that form aneurysms are typically
muscular, and occur along with the vasa vasorum (e.g.,
coronary artery, axillary artery, internal iliac artery),
edema and cell infiltration are also seen at arterioles, ve-
nules, and microvessels. The pathophysiology of coron-
ary aneurysms remains unclear, however, we hypothesize
that both endothelial cell disorders and inflammation of
the vasa vasorum are involved. If there is prolonged
edema of the microvessels, the supply of oxygen to the
coronary artery wall through the vasa vasorum will be
compromised, and the coronary media may thus become
ischemic. Hence, the coronary artery structure becomes
very fragile [37].
As previously noted, we believe that after the develop-
ment of inflammation around micro arteries in the ad-
ventitia, the neovascularization diverges from the vasa
vasorum and proliferates toward the media and the in-
tima to supply blood, inflammatory cells, cytokines and
chemokines in order to quell the inflammation.
The vasa vasorum have been of considerable interest
to scientists and physicians for more than a century
[38,39]. They nurture the outer component of the vessel
wall, including the adventitia and outer one-third of the
media, and the intima is supplied with oxygen from the
lumen [30]. Under normal conditions, the vasa vasorum
run longitudinally along the long axis of the adventitia
of the blood vessels (primary vasa vasorum), and in
some places, flow into the adventitia and the media (sec-
ond vasa vasorum).When any injury or inflammation of
blood vessels occurs (e.g., arterial sclerosis), the vasa
vasorum proliferate and penetrate into the adventitia
[13] and the media, thus buttressing the capillary net-
work [14].
Developments in diagnostic imaging have allowed the
microvessels inside lesions to be detected if the neointimais thicker than 500 μm. Furthermore, any infiltration of
microvessels from the adventitia into the vessels can now
be visualized [15].In inflammatory lesions, the permeabil-
ity of microvessels can be seen in the acute phase as these
microvessels expand or progress. Hypoxia and endothelial
reactions are the major driving forces behind the progres-
sion of the vasa vasorum [40]. Moreover, there is a dispro-
portionate increase in growth factors for the endothelium
of the vasa vasorum, and further development of the vasa
vasorum causes the plasma to extravasate around the vasa
vasorum.
Conclusions
In conclusion, we investigated the involvement of the
vasa vasorum in the KD like vasculitis using a murine
model induced by CAWS. We demonstrated that the
vasa vasorum might serve as the initiator of vasculitis in
this model. Initially, the inflammatory cells accumulated
at the adventitia, and then diverged through neovascu-
larization toward the media and the intima. Therefore,
the vasa vasorum provides a critical route for the infil-
tration of inflammatory cells. The proliferation of the
new vasa vasorum toward the media and the intima is
an important criterion for both the expansion and the
termination of the inflammation.
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